Skip to main content
Clinical Trials/ACTRN12621001244897
ACTRN12621001244897
Recruiting
未知

The efficacy of an eHealth prevention and early intervention program targeting eating disorder symptoms in adults.

Deakin University0 sites576 target enrollmentSeptember 15, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Eating disorders
Sponsor
Deakin University
Enrollment
576
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 15, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adults aged 18 and over who may have a subclinical or full eating disorder diagnosis for the main ED subtypes, specifically bulimia nervosa (BN), binge eating disorder (BED), body dysmorphia disorder (BDD; specific to dysmorphia with the body rather than face), other specified feeding or eating disorder (OSFED), and unspecified feeding or eating disorder (UFED). Diagnosis information will be self\-reported in the baseline survey and a clinical phone interview will also be completed to determine eligibility.
  • In addition, the baseline online survey includes several screening questions to identify those who will probably meet the clinical/subclinical threshold for inclusion into the study. These items ask whether participants have dieted during the past 6 months, and whether they have been concerned about their body, body image, or physical appearance during the past 6 months. These two items are based on prior eHealth interventions for body image and ED, and provide a good screener to reduce the number of phone interviews required overall.
  • Finally, access to a smartphone throughout duration of 10\-week intervention phase of research participation is a necessary inclusion criterion for the study.

Exclusion Criteria

  • Participants with a diagnosis of (or symptoms consistent with) Anorexia Nervosa (AN; including Atypical AN), Avoidant/restrictive food intake disorder (ARFID), Pica, Rumination Disorder, and BDD (specific to dysmorphia related to facial rather than bodily appearance) will not be eligible to participate. These individuals will instead be provided with referral information for treatment and support.
  • Our baseline survey includes a question about suicidality (‘Over the last 2 weeks, how often have you had thoughts that you would be better off dead or hurting yourself in some way?’). Participants who answer above zero (not at all”) will be excluded from the study, and instead recommended free counselling options such as lifeline, as well as being made aware of GP referral to psychologists.

Outcomes

Primary Outcomes

Not specified

Similar Trials